Nuvation Bio
NUVB
244 hedge funds and large institutions have $1.33B invested in Nuvation Bio in 2026 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 111 increasing their positions, 52 reducing their positions, and 25 closing their positions.
978% more call options, than puts
Call options by funds: $38M | Put options by funds: $3.53M
113% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 52
60% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 25
40% more capital invested
Capital invested by funds: $947M → $1.33B (+$378M)
5% more funds holding
Funds holding: 233 → 244 (+11)
3.38% more ownership
Funds ownership: 63.65% → 67.03% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.4M |
| 2 |
HF
HRT Financial
New York
|
+$10.8M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$7.83M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$6.37M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$5.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHC
Jones Hill Capital
New York
|
-$10.2M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$8.58M |
| 3 |
Two Sigma Investments
New York
|
-$7.02M |
| 4 |
Millennium Management
New York
|
-$3.66M |
| 5 |
Morgan Stanley
New York
|
-$2.02M |
NUVB Hedge Fund Activity: Q2 2026 in Review
244 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q2 2026, worth a combined $1.33B — up 40% from $947M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new NUVB positions and 25 closed out — a net gain of 15 holders — while 111 added to existing stakes and 52 trimmed.
The largest buyer was BlackRock, adding an estimated $12.4M. The largest seller was Jones Hill Capital, exiting entirely with an estimated $10.2M sold.
- 244 institutional investors held Nuvation Bio (NUVB) as of Q2 2026, up from 233 in Q1 2026.
- Funds reported $1.33B of Nuvation Bio stock for Q2 2026, up 40% quarter-over-quarter.
- 40 funds opened new Nuvation Bio positions in Q2 2026 and 25 closed out, a net change of +15 holders.
- The largest Nuvation Bio buyer in Q2 2026 was BlackRock, an estimated $12.4M added.
- The largest Nuvation Bio seller in Q2 2026 was Jones Hill Capital, an estimated $10.2M sold.
Based on aggregated 13F filings for Q2 2026.